Respiratory Problems of HIV Infection and AIDS

  • Ann Millar

Abstract

At present, the lungs are affected more commonly in the acquired immunodeficiency syndrome (AIDS) than any other organ system (Hope and Luce 1985; Murray et al. 1984, 1987; Murray and Mills 1990). Furthermore one respiratory illness alone, pneumocystis carinii pneumonia (PCP), will occur in 75% of patients who are antibody positive for the human immunodeficiency virus (HIV-positive) at some point in their disease without prophylactic treatment and still accounts for up to 50% of initial presentations of AIDS.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Advisory committee for the elimination of tuberculosis (1989) Tuberculosis and human immunodeficiency virus infection. MMWR 38: 236–238, 243–250Google Scholar
  2. Agnostini C, Trentin L, Zamballo, Semenzato G (1993) HIV-1 and the lung. Am Rev Respir Dis 147: 1038–49Google Scholar
  3. Allegra CJ, Chabner BA, Tuuazon CU et al. (1987) Trimetrexate for the treatment of Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. NEJM 317: 978–985Google Scholar
  4. Allen JR, Currann JW (1985) Epidemiology of the acquired immunodeficiency syndrome. In: Gallin JI, Fauci AS (eds.) Advances in host defence mechanism, Vol 5. Raven Press, New York, pp 1–17Google Scholar
  5. American Thoracic Society/Centres for Disease Control (1987) Mycobacterioses and the acquired immunodeficiency syndrome. Am Rev Resp Dir 138: 492–496Google Scholar
  6. Autran B, Mayaud B, Guillon JM et al. (1988) Evidence for a cytotoxic T lymphocyte alveolitis in human immunodeficiency-virus infected patients. AIDS 24: 179–183Google Scholar
  7. Barta K (1969) Complement fixation test for Pneumocystis. Ann Intern Med 70: 235PubMedGoogle Scholar
  8. Bigby T, Margolskee D, Curtis J et al. (1986) The usefulness of direct sputum in the diagnosis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. Am Rev Resp Dis 133: 515–518PubMedGoogle Scholar
  9. Black JR, Feinberg J, Murphy RL (1994) Clindamycin and primaquine therapy for mild to moderate episodes of Pneumocystis carinii pneumonia in patients with AIDS: AIDS clinical trials group 044. Clin Infect Dis 18: 905–913PubMedGoogle Scholar
  10. Bozzette SA, Sattler FR, Chiu J et al. (1990) A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii in the acquired immunodeficiency syndrome. N Engl J Med 323: 1351–1457Google Scholar
  11. Byberg IC, Lund JT, Hording M (1988) Effect of folic and folinic acid on cytopenia occurring during cotrimoxazole treatment of Pneumocystis carinii pneumonia. Scand J Infect Dis 20: 685–686.Google Scholar
  12. Cameron W et al. (1992) Rifabutin therapy for the prevention of M avium complex (MAC) bacteraemia in patients with AIDS and CD4 200.VIII Intl Conf AIDS, Amsterdam, abstract WeB 1052Google Scholar
  13. Centers for Disease Control (1986) Tuberculosis United States, 1985 and the possible impact of human T-lymphotropic virus type III/lymphadenopathy-associated virus infection. MMWR 36: 385–389Google Scholar
  14. Centers for Disease Control (1992) 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 41 (RR-11): 1–19Google Scholar
  15. Chak L et al. (1988) Radiation therapy for acquired immunodeficiency syndrome related Kaposi’s sarcoma. J Clin Oncol 6: 863–867PubMedGoogle Scholar
  16. Chaisson RE, Hopewell PC (1989) Mycobacteria and AIDS mortality. Am Rev Respir Dis 139: 1–3PubMedGoogle Scholar
  17. Chaisson RE, Moore RD, Richman DD et al. (1992) Incidence and natural history of Mycobacterium Avium-complex in patients with advanced human immunodeficiency virus disease treated with zidovudine. Am Rev Respir Dis 146: 285–289PubMedGoogle Scholar
  18. Chaisson RE, Schecter GF, Theur CP et al. (1987) Tuberculosis in patients with the acquired immunodeficiency syndrome. Am Rev Resp Dis 136: 570–574PubMedGoogle Scholar
  19. Chayt KS, Harper ME, Marselle LM et al. (1986) Detection of HTLV III RNA in lungs of patients with AIDS and pulmonary involvement 256: 2356–2359Google Scholar
  20. Chew T et al. (1992) A phase II clinical trial of VS103 (liposomal daunorubicin). VIII Intl Conf AIDS, Amsterdam, abstract PoB 3106Google Scholar
  21. Clarke JR, Fleming J, Donegan K et al. (1991) Effect of HIV-1 and cytomegalovirus in bronchoalveolar lavage cells on the transfer factor for lung carbon monoxide in AIDS patients. AIDS 5: 1333–1338PubMedGoogle Scholar
  22. Coker RJ, Nieman R, McBride M et al. (1992) Cotrimoxazole versus dapsone-pyrimethamine for prevention of Pneumocystis carinii pneumonia. Lancet 330: 1099Google Scholar
  23. Coleman DL, Hattner RS, Luce JA, Dodek PM, Golden JA, Murray JF (1984) Correlation between gallium lung scans and fibreoptic bronchoscopy in patients with suspected Pneumocystis carinii pneumonia and the acquired immune deficiency syndrome. Am Rev Resp Dis 130: 1166–1169PubMedGoogle Scholar
  24. Coleman DL, Dodek PM, Golden JA (1984) Correlation between serial pulmonary function tests and fibreoptic bronchoscopy in patients with Pneumocystis carinii pneumonia and the acquired immune deficiency syndrome. Am Rev Resp Dis 129: 491–493.PubMedGoogle Scholar
  25. Collaborative DHPG study group (1986) Treatment of serious cytomegalovirus infection with 9-(l,3- dihydroxy-2-propoxymethyl) guanine in patients with AIDS and other immunodeficiencies. N Engl J Med 314: 801–805Google Scholar
  26. De Lorenzo LJ, Huang CT, Mcguire GP, Stone DJ (1987) Roentgenographic patterns of Pneumocystis carinii pneumonia in 104 patients with AIDS. Chest 91: 323–327Google Scholar
  27. Denison DM, Cramer DS, Hanson PJV (1989) Lung function testing and AIDS. Respir Med 83: 133–138PubMedGoogle Scholar
  28. Dormann L et al. (1992) Liposomal-encapsulated cytotoxic agent daunorubicin (LD) versus conventional three drug chemotherapy (cc) in AIDS patients with Kaposi’s sarcoma - preliminary results. Third European conference on clinical aspects and treatment of HIV Infection, Paris: abstract 09Google Scholar
  29. Edman JC, Kovacs JA, Masur H, Santi DV, Elwood HJ, Sogun ML (1988) Ribosomal RNA sequences show Pneumocystis carinii to be a member of the fungi. Nature 334: 519 - 522PubMedGoogle Scholar
  30. El-Sadr W, Simberkoff MS (1988) Survival and prognostic factors in severe Pneumocystis carinii pneumonia requiring mechanical ventilation. Am Rev Resp Dis 137: 1264–1267PubMedGoogle Scholar
  31. Engelberg LA, Lerner CW, Tapper ML (1984) Clinical features of Pneumocystis pneumonia in patients with the acquired immunodeficiency syndrome. Am Rev Resp Dis 130: 689 - 694PubMedGoogle Scholar
  32. Fischol MA (1988) Treatment and prophylaxis of Pneumocystis carinii pneumonia. AIDS 2 (Suppl 1): S143–150Google Scholar
  33. Fischl MA, Dickinson GM, La Voie L (1988) Safety and efficacy of sulphamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS. JAMA 259: 1185–1189PubMedGoogle Scholar
  34. Fitzgerald W, Bevalaqua FA, Garay SM, Aranda CP (1987) The role of open lung biopsy in the acquired immunodeficiency syndrome. Chest 135: 422–425Google Scholar
  35. Girard PM, Gaudebout C, Lepetre A et al. (1989) Prevention of Pneumocystis carinii pneumonia by pentamadine aerosol in zidovudine-treated AIDS patients. Lancet i: 1348–1352Google Scholar
  36. Girard PM, Landman R, Gaudebout C et al. (1993) Dapsone-pyrimethamine compared with aerosolised pentamadine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. N Engl J Med 328: 1514–1520PubMedGoogle Scholar
  37. Golden JA, Sjoerdsma A, Santi DV (1984) Pneumocystis carinii pneumonia treated with adifluromethylornithine: a prospective study among patients with the acquired immune deficiency syndrome. West J Med 141: 612–623Google Scholar
  38. Goodman JL, Tashki DP (1983) Pneumocystis with normal chest x-ray film and arterial oxygen tension. Early diagnosis in a patient with the acquired immune deficiency syndrome. Ann Intern Med 81: 11–18Google Scholar
  39. Goodman PC, Broaddus VC, Hopewell PC (1984) Chest radiographic patterns in the acquired immune deficiency syndrome. Am Rev Resp Dis 130: 689–694Google Scholar
  40. Gordin FM, Simon GL, Wofsy CB et al. (1984) Adverse reactions to trimethoprim-sulphamethoxazole in patients with the acquired immunodeficiency syndrome. Ann Intern Med 100: 495–499PubMedGoogle Scholar
  41. Gordin FM et al. (1992) Rifabutin monotherapy prevents or delays Mycobacterium avium complex (MAC) bacteraemia in patients with AIDS. VIII Intl Conf AIDS, Amsterdam, abstract PoB 3172Google Scholar
  42. Gottlieb MS, Knight S, Mitsiyasu R, Weisman J, Roth M, Young LS (1984) Prophylaxis of Pneumocystis infection in AIDS with pyrimethamine-sulfadoxine. Lancet i: 388–389Google Scholar
  43. Grieco MH, Chinoy-Acharya P (1985) Lymphocytic interstitial pneumonia associated with the acquired immune deficiency syndrome. Am Rev Resp Dis 131: 952–955PubMedGoogle Scholar
  44. Grundy JE, Shenley JD, Griffiths PD (1987) Is cytomegalovirus interstitial pneumonitis in transplant patients an immunopathologic condition. Lancet ii: 996–998Google Scholar
  45. Hanson PJV, Harcourt-Webster JN, Gazzard BG, Collins JV (1987) Fibreoptic bronchoscopy in the diagnosis of bronchopulmonary Kaposi’s sarcoma. Thorax 42: 269–271PubMedGoogle Scholar
  46. Hardy WD, Feinberg J, Finkelstein DM et al. (1992) A controlled trial of trimethoprim- sulphamethoxazole or aerosolised pentamadine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. N Engl J Med 327: 1842–1848PubMedGoogle Scholar
  47. Hartman TE, Primack SL, Muller NL, Staples CA (1994) Diagnosis of thoracic complications in AIDS; accuracy of CT. AJR 162: 547–553Google Scholar
  48. Hattner RS, Solitto RA, Golden JA, Coleman DL, Okerland MD (1984) Sensitivity and specificity of Ga-67 pulmonary scans for the detection of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome and pulmonary symptoms J Nucl Med 25: 43Google Scholar
  49. Hawkins CC, Gold JWM, Whimbey E et al. (1986) Mycobacterium avium complex infections with the acquired immunodeficiency syndrome. Ann Intern Med 105: 184–188PubMedGoogle Scholar
  50. Helbert M, Robinson D, Buchanan D et al. (1990) Mycobacterial infection in patients infected with the human immunodeficiency virus. Thorax 45: 45–48PubMedGoogle Scholar
  51. Hirsch MS (1992) The treatment of cytomegalovirus in AIDS - more than meets the eye. N Engl J Med 326: 264–266PubMedGoogle Scholar
  52. Hirsch MS, Wormser GP, Schooley RT et al. (1985) Risk of nosocomial infection with human T-cell lymphotropic virus (HLTV-111). N Engl J Med 312: 1–4PubMedGoogle Scholar
  53. Ho DD, Byington RE, Schooley RT, Flynn T, Rota TR, Hirsch MS (1985) Frequency of isolation of HTLV-III from saliva in AIDS. N Engl J Med 313: 1606Google Scholar
  54. Hopewell PC, Luce JM (1985) Pulmonary involvement in the acquired immunodeficiency syndrome Chest 87: 104–112PubMedGoogle Scholar
  55. Horsburgh CR Jr, Selik RM (1989) The epidemiology of disseminated non-tuberculous mycobacterial infection in the acquired immunodeficiency syndrome ( AIDS ). Am Rev Respir Dis 139: 4–7Google Scholar
  56. Hughes WT, Gray VL, Gutteridge WE, Latter VS, Pudney M (1990) Efficacy of a hydroxynaph- thaquone, 566C80, in experimental Pneumocystis carinii pneumonia. Antimicrob Agents Chemother 43: 225–228Google Scholar
  57. Hughes W, Leoung G, Kramer F et al. (1993) Comparison of atavaquone (566C80) with trimethoprim-sulphamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS. N Engl J Med 328: 1521–527PubMedGoogle Scholar
  58. Jacobson MA (1988) Mycobacterial disease: tuberculosis and mycobacterium avium complex. Infect Dis Clin North Am 2: 465–474PubMedGoogle Scholar
  59. Jeffrey AA, Israel-Biet D, Andrieu JM et al. (1991) HIV isolation from pulmonary cell derived from bronchoalveolar lavage. Clin Exp Immunol 85: 488–492Google Scholar
  60. Joint Tuberculous Committee of the British Thoracic Society (1992) Guidelines on the management of tuberculosis and HIV in the United Kingdom. Br Med J 304: 1231–1233Google Scholar
  61. Kesten S, Rebuck AS (1988) Continuous positive airways pressure in Pneumocystis carinii pneumonia. Lancet ii: 1414–1415Google Scholar
  62. Klein N, Duncanson FP, Lenox TH et al. (1992) Trimethoprim-sulphamethoxazole versus pentamadine for Pneumocystis carinii pneumonia in AIDS patients: results of a large prospective randomised trial. AIDS 6: 301–305PubMedGoogle Scholar
  63. Kovacs JA, Ng VL, Masur H et al. (1988) Diagnosis of Pneumocystis carinii pneumonia: improved detection in sputum with use of monoclonal antibodies. N Engl J Med 318: 589–593PubMedGoogle Scholar
  64. Kramer EL, Sanger JJ, Garay SM (1987) Gallium-67 scans of the chest in patients with acquired immunodeficiency syndrome. J Nucl Med 28: 1107–1114PubMedGoogle Scholar
  65. Krown SE (1988) AIDS-associated Kaposi’s sarcoma; pathogenesis, clinical course and treatment. AIDS 242: 426–430Google Scholar
  66. Kvale PA, Rosen MJ, Hopewell PC et al. (1993) A decline in the pulmonary diffusing capacity does not indicate opportunistic lung disease in asymptomatic persons infected with the human immunodeficiency virus. Am Rev Respir Dis 148: 390–395PubMedGoogle Scholar
  67. Leoung GS, Feigal DW Jr, Montgomery AB et al. (1990) Aerosolised pentamadine for prophylaxis against Pneumocystis carinii pneumonia - the San Francisco Community prophylaxis trial. N Engl J Med 323: 769–775PubMedGoogle Scholar
  68. Luce JM, Wächter RM, Hopewell PC (1988) Intensive care of patients with the acquired immunodeficiency syndrome: time for a reassessment? Am Rev Resp Dis 137: 1261–1263PubMedGoogle Scholar
  69. Magenat J-L, Nicod LP, Auckenthaler R, Junod AF (1991) Mode of presentation and diagnosis of bacterial pneumonia in human immunodeficiency virus infected patients. Am Rev Respir Dis 144: 917–922Google Scholar
  70. Masur H, Ognibene FP, Yarchoan R et al. (1989) CD4 counts as predictors of the opportunistic pneumonia in human immunodeficiency virus ( HIV) infection. Ann Intern Med 111: 223–231PubMedGoogle Scholar
  71. Masur H, Meier P, McCutchen JA et al. (1990) Consensus statement on the use of corticosteroids as adjunctive therapy for Pneumocystis pneumonia ( PCP) in the acquired immunodeficiency syndrome. N Engl J Med 323: 1500–1514Google Scholar
  72. Mayoud CM, Cadranel J (1993) HIV in the lung: guilty or not guilty? Thorax 48: 1191–1195Google Scholar
  73. Medina I, Mills J, Leoung G et al. (1990) Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of Trimethoprim-Sulphamoxazole versus trimethoprim-dapsone. New Engl J Med 323: 776–782PubMedGoogle Scholar
  74. Meduri GU, Stover DE, Lee M et al. (1986) Pulmonary Kaposi’s sarcoma in the acquired immuno-deficiency syndrome. Am J Med 81: 11–18PubMedGoogle Scholar
  75. Meinert CL et al. (1992) Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or gancyclovir for cytomegalovirus retinitis. New Engl J Med 326: 213–220Google Scholar
  76. Meyer JL (1993) Whole lung irradiation for Kaposi’s sarcoma. Am J Clin Oncol 16: 372–376Google Scholar
  77. Millar AB, Patou G, Miller RF et al. (1990) Cytomegalovirus in the lungs of patients with AIDS: respiratory passenger or pathogen? Am Rev Resp Dis 145: 1474–1477Google Scholar
  78. Millar AB, Mitchell DM (1990) Non-invasive investigation of pulmonary disease in patients positive for the human immunodeficiency virus. Thorax 45: 57–61PubMedGoogle Scholar
  79. Miller RF, Semple SJG (1991) Continuous positive airway pressure ventilation for respiratory failure associated with Pneumocystis carinii pneumonia. Respir Med 65: 133–138Google Scholar
  80. Miller RF, Godfrey-Fausett P, Semple SJG et al. (1989) Nebulised pentamadine as treatment for Pneumocystis carinii pneumonia in the acquired immune deficiency syndrome. Thorax 44: 565–569PubMedGoogle Scholar
  81. Miller RF, Foley NM, Kessel D, Jeffrey A A (1994) Community acquired lobar pneumonia in patients with HIV infection and AIDS. Thorax 49: 367–368PubMedGoogle Scholar
  82. Milligan SA, Stulbarg MS, Gamsu G, Golden JA (1985) Pneumocystis carinii pneumonia radiographically simulating tuberculosis. Am Rev Resp Dis 132: 1124–1126PubMedGoogle Scholar
  83. Mills J, Leoung G, Medina I et al. (1988) Dapsone treatment of Pneumocystis carinii pneumonia in acquired immunodeficiency syndrome. Antimicrob Agents Chemother 32: 1057–1060PubMedGoogle Scholar
  84. Mitchell DM, Fleming J, Pinching AJ et al. (1992) Pulmonary function in human immunodeficiency virus infection. A prospective 18-month study of serial lung function in 474 patients. Am Rev Respir Dis 146: 745–751PubMedGoogle Scholar
  85. Montaner JSG et al. (1991) Aerosol pentamadine for secondary prophylaxis of AIDS-related PCP. A randomised placebo-controlled study. Ann Int Med 114: 948–953PubMedGoogle Scholar
  86. Montgomery AB, Luce JM, Turner J et al. (1987) Aerosolised pentamadine as sole therapy for Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. Lancet ii: 480–483Google Scholar
  87. Murphy RL et al. (1991) Aerosol pentamadine prophylaxis following PCP in AIDS patients: results of a double blind dose-comparison using an ultrasonic nebuliser. Am J Med 90: 418–426PubMedGoogle Scholar
  88. Murray JF (1989) The white plague: down and out or up and coming? Am Rev Respir Dis 140: 1788–1795PubMedGoogle Scholar
  89. Murray JF, Mills J (1990) Pulmonary infectious complications of human immunodeficiency virus infection. Part I and II. Am Rev Respir Dis 141: 1356–72, 1582–1598Google Scholar
  90. Murray JF, Felton CP, Garay SM et al. (1984) Pulmonary complications of the acquired immune deficiency syndrome: a report of a National Heart, Lung and Blood Workshop. N Engl J Med 310: 1682–1688PubMedGoogle Scholar
  91. Murray JF, Felton CP, Garay S et al. (1987) Pulmonary complications of the acquired immunodeficiency syndrome: an update. Am Rev Resp Dis 135: 504–509PubMedGoogle Scholar
  92. Naidich DP, Garay SM, Lutman BS, McCauley DI (1987) Radiographic manifestations of pulmonary disease in the acquired immunodeficiency syndrome ( AIDS ). Semin Roentgenol 22: 14–30Google Scholar
  93. Naidich DP, McGuiness G (1991) Pulmonary manifestations of AIDS: CT and radiographic correlations. Radiol Clin N Amer 29: 999–1017Google Scholar
  94. Nieman RB, Fleming J, Coker RJ, Harris JRW, Mitchell DM (1993) Reduced carbon monoxide transfer factor (TLCO) in human immunodeficiency virus type I ( HIV-I) infection as a predictor for faster progression to AIDS. Thorax 48: 481–485Google Scholar
  95. O’Doherty MJ, Page CJ, Bradbeer CS et al. (1989) The place of 99mTc DTPA aerosol transfer in the investigation of lung infections in HIV-positive patients. Respir Med 5: 395–401Google Scholar
  96. O’Doherty MJ, Thomas S, Page C et al. (1990) Pulmonary deposition of nebulised pentamadine isethionate: effect of nebuliser type, dose and volume of fill. Thorax 45: 460–464PubMedGoogle Scholar
  97. O’Doherty MJ, Nunan TO (1993) Nuclear medicine and AIDS. Nucl Med Commun 14: 830–848PubMedGoogle Scholar
  98. Ognibene FP, Steis RG, Macher AM et al. (1985) Kaposi’s sarcoma causing pulmonary infiltrates and respiratory failure in the acquired immunodeficiency syndrome. Ann Intern Med 102: 471–475PubMedGoogle Scholar
  99. Ognibene F, Masyr A, Rogers P (1988) Non-specific interstitial pneumonitis without Pneumocystis carinii pneumonia in asymptomatic patients infected with human immunodeficiency virus. Ann Intern Med 109: 874–879PubMedGoogle Scholar
  100. Orenstein M, Weber CA, Cash M, Heurich AE (1986) Value of broncho-alveolar lavage in the diagnosis of pulmonary infection in acquired immune deficiency syndrome. Thorax 41: 345–349PubMedGoogle Scholar
  101. Overland ES, Nolan A J, Hopewell PC (1980) Alteration of pulmonary function in intravenous drug abusers: prevalence, severity and characterisation of gas exchange abnormalities. Am J Med 68: 231–237PubMedGoogle Scholar
  102. Pifer LL, Hughes WT, Stagno S et al. (1978) Pneumocystis carinii infection: evidence for high prevalence in normal and immunocompromised children. Paediatrics 61: 35–41Google Scholar
  103. Pillay D, Lipman MIC, Lee CA et al. (1993) A clinico-pathological audit of opportunistic viral infections in HIV-infected patients. AIDS 7: 968–974Google Scholar
  104. Pitchenik AE, Ganjei P, Torres A et al. (1986) Sputum examination for the diagnosis of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Am Rev Resp Dis 133: 515–518Google Scholar
  105. Pitkin AD, Grant AD, Foley NM et al. (1993) Changing patterns of respiratory disease in HIV positive patients in a referral centre in the United Kingdom between 1986–7 and 1990-1. Thorax 48: 204–207PubMedGoogle Scholar
  106. Polsky B, Gold JWM, Whimbey E et al. (1986) Bacterial pneumonia in patients with the acquired immunodeficiency syndrome. Ann Intern Med 104: 38–41PubMedGoogle Scholar
  107. Rosso J, Picard C, Mayard C, Revuz J, Meignan M (1986) Comparison of 99 m TC DTPA aerosol and gallium scans in early detection of Pneumocystis carinii pneumonia in acquired immune deficiency syndrome. J Nucl Med 27: 951Google Scholar
  108. Ruskin J, LaRiviere M (1991) Low dose cotrimoxazole for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus disease. Lancet 337: 468–471PubMedGoogle Scholar
  109. Sands M, Kron MA, Brown RB (1985) Pentamadine. A review. Rev Infect Dis 7: 625–637Google Scholar
  110. Sattler FR, Frame P, Davis R et al. (1993) Trimetrexate with leucoverin versus trimethoprim- sulphamethoxazole for moderate to severe episodes of Pneumocystis carinii pneumonia in patients with AIDS: a prospective, controlled multicentre investigation of the AIDS clinical trials group protocol 029/031. J Infect Dis 170: 165–172Google Scholar
  111. Schneider MME, Hoepelman AIM, Efftink Shattenkerk JKM et al. (1992) A controlled trial of aerosolised pentamadine or trimethoprim-sulphamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. N Engl J Med 327: 1826–1841Google Scholar
  112. Selwyn PA, Härtel D, Lewis VA et al. (1989) A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 320: 545–550PubMedGoogle Scholar
  113. Shaw RJ, Roussak C, Forster SM, Harris JW, Pinching AJ, Mitchell DM (1988) Lung function abnormalities in patients infected with the human immunodeficiency virus with and without overt pneumonitis. Thorax 43: 436–440PubMedGoogle Scholar
  114. Simmons JT, Suffredini AF, Lack EE et al. (1987) nonspecific interstitial pneumonitis in patients with SIDS: radiologic features. AJR 149: 265–268Google Scholar
  115. Small PM et al. (1991) Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. New Engl J Med 324: 289–294PubMedGoogle Scholar
  116. Smith DE, McLuckie A, Wyatt J, Gazzard B (1988) Severe exercise hypoxaemia with normal or near normal x-rays: a feature of Pneumocystis carinii infection. Lancet ii: 1049–1051Google Scholar
  117. Smith D, Davies S, Nelson M et al. (1990) Pneumocystis carinii pneumonia treated with eflornithine in AIDS patients resistant to conventional therapy. AIDS 4: 1019–1021PubMedGoogle Scholar
  118. Smith RL, Ripps CS, Lewis ML (1988) Elevated lactate dehydrogenase values in patients with Pneumocystis carinii pneumonia. Chest 93: 987–992PubMedGoogle Scholar
  119. Solal-Celigny P, Coudere LJ, Herman D et al. (1985) Lymphoid interstitial pneumonitis in the acquired immunodeficiency syndrome-related complex. Am Rev Resp Dis 131: 956–960PubMedGoogle Scholar
  120. Squire SB, Lipman MCI, Bagdades EK et al. (1992) Severe cytomegalovirus pneumonitis in HIV infected patients with higher than average CD4 counts. Thorax 47: 301–304PubMedGoogle Scholar
  121. Staikowsky F, Lafon B, Guidet B, Denis M, Mayaud C, Offenstadt G (1993) Mechanical ventilation for Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome: is the prognosis really improved? Chest 104: 756–762PubMedGoogle Scholar
  122. Stern RG, Gamsu G, Golden JA (1984) Intrathoracic adenopathy: differential features of AIDS and diffuse lymphadenopathy syndrome. AJR 142: 689–692Google Scholar
  123. Stover DE, White DA, Romano PA et al. (1985) Spectrum of pulmonary disease associated with the acquired immunodeficiency syndrome. Am J Med 78: 429–437PubMedGoogle Scholar
  124. Stover DE, Greeno RA, Gagliardi AJ (1989) The use of a simple exercise test for the diagnosis of Pneumocystis carinii pneumonia in patients with AIDS. Am Rev Resp Dis 139: 1343–1346PubMedGoogle Scholar
  125. Stover DE, White DA, Roomano PA, Gellene RA (1984) Diagnosis of pulmonary disease in acquired immune deficiency syndrome (AIDS). Role of bronchoscopy and broncho-alveolar lavage. Am Rev Resp Dis 131: 659–662Google Scholar
  126. Suffredini AF, Ognibene FP, Lack EE et al. (1987) Nonspecific interstitial pneumonitis. A common cause of pulmonary disease in the acquired immunodeficiency syndrome. Ann Intern Med 107: 7–13PubMedGoogle Scholar
  127. Suster B, Ackerman M, Orenstein M, Wax MR (1986) Pulmonary manifestation of AIDS: review of 106 episodes. Radiology 161: 87–93PubMedGoogle Scholar
  128. Tanabe K, Fuchimoto M, Egawa K et al. (1988) Use of Pneumocystis carinii genomic DNA clones for hybridisation analysis of infected human lungs. J Infect Dis 157: 593–596PubMedGoogle Scholar
  129. Thuer CP, Chaisson RE, Sheckter GF, Hopewell PC (1988) Human immunodeficiency virus infection in tuberculosis patients in San Francisco. Am Rev Respir Dis 137: 121 (abstract)Google Scholar
  130. Toma E, Fournier S, Poisson M et al. (1989) Clindamycin with primaquine for Pneumocystis carinii pneumonia. Lancet i: 1046–1048Google Scholar
  131. Wakefield AE, Guiver L, Miller RF, Hopkin JM (1991) DNA amplification on induced sputum samples for the diagnosis of Pneumocystis carinii pneumonia. Lancet 337: 1378–1379PubMedGoogle Scholar
  132. Wakefield AE, Peters SE, Baberji S et al. (1992) Pneumocystis carinii shows DNA homology with the ustomycetous red yeast fungi. Mol Microbiol 6: 1903–1911PubMedGoogle Scholar
  133. Wallace JM, Hannah JB (1988) Pulmonary disease at autopsy in patients with the acquired immunodeficiency syndrome. West Med J 149: 167–171Google Scholar
  134. Wallace JM, Rao AV, Glassroth et al. (1993) Respiratory illness in persons with human immunodeficiency virus infection. Am Rev Respir Dis 148: 1523–1529PubMedGoogle Scholar
  135. Walzer PD (1988) Diagnosis of Pneumocystis carinii pneumonia. J Infect Dis 157: 629–632PubMedGoogle Scholar
  136. Walzer PD, Cuslion MT, Juranek D et al. (1987) Serology and Pneumocystis carinii. Chest 91: 935PubMedGoogle Scholar
  137. Warren JB, Shaw RJ, Weber JN, Holt DA, Keel EE, Pinching AJ (1985) Role of fibreoptic bronchoscopy in management of pneumonia in acquired immune deficiency syndrome. Br Med J 291: 1012–1013Google Scholar
  138. Watson JM, Fern KJ, Porter JDH, Whitmore SE (1991) Notifications of tuberculosis in England and Wales, 1982–1989. Communicable Diseases Report 1: R13 - 16Google Scholar
  139. Watson JM, Meredith SK, Whitmore-Overton E, Bannister B, Darbyshire JH (1993) Tuberculosis and HIV: estimates of the overlap in England and Wales. Thorax 48: 199–203PubMedGoogle Scholar
  140. Webster A et al. (1989) CMV infection and progression towards AIDS in patients with HIV infection. Lancet i: 63–66Google Scholar
  141. Wharton M, Coleman DL, Wofsy C et al. (1986) Prospective randomised trial of trimethoprim- sulphamethoxole versus pentamidine for Pneumocystis carinii pneumonia in the acquired immune deficiency syndrome. Ann Intern Med 105: 37–44PubMedGoogle Scholar
  142. Youle M, Chanas A, Gazzard B (1990) Treatment with foscarnet of presumed CMV pneumonitis in patients with AIDS; a double-blind controlled study. J Infect 20: 41–50PubMedGoogle Scholar
  143. Young LS (1987) Antigen detection in Pneumocystis carinii infection. Serodiagnosis Immunotherapy 1: 163–167Google Scholar
  144. Zaman MK, Wooten OJ, Supra Manya B et al. (1988) Rapid non-invasive diagnosis of Pneumocystis carinii from induced liquefied sputum. Ann Intern Med 109: 7–10PubMedGoogle Scholar
  145. Zaman MK, White DA (1988) Serum lactate dehydrogenase levels and Pneumocystis carinii pneumonia. Diagnostic and prognostic significance. Am Rev Resp Dis 137: 796–800PubMedGoogle Scholar
  146. Ziegler JL, Beckstead JA, Volberding PA et al. (1984) Non-Hodgkin’s lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immune deficiency syndrome. N Engl J Med 311: 565–570PubMedGoogle Scholar

Copyright information

© Springer-Verlag London Limited 1996

Authors and Affiliations

  • Ann Millar

There are no affiliations available

Personalised recommendations